456 related articles for article (PubMed ID: 24659241)
1. TDP-43 is a key player in the clinical features associated with Alzheimer's disease.
Josephs KA; Whitwell JL; Weigand SD; Murray ME; Tosakulwong N; Liesinger AM; Petrucelli L; Senjem ML; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Jack CR; Parisi JE; Petersen RC; Dickson DW
Acta Neuropathol; 2014; 127(6):811-24. PubMed ID: 24659241
[TBL] [Abstract][Full Text] [Related]
2. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.
Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW
Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156
[TBL] [Abstract][Full Text] [Related]
3. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.
Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA
JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.
Yang HS; Yu L; White CC; Chibnik LB; Chhatwal JP; Sperling RA; Bennett DA; Schneider JA; De Jager PL
Lancet Neurol; 2018 Sep; 17(9):773-781. PubMed ID: 30093249
[TBL] [Abstract][Full Text] [Related]
5. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
[TBL] [Abstract][Full Text] [Related]
6. Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.
Buciuc M; Wennberg AM; Weigand SD; Murray ME; Senjem ML; Spychalla AJ; Boeve BF; Knopman DS; Jack CR; Kantarci K; Parisi JE; Dickson DW; Petersen RC; Whitwell JL; Josephs KA
J Alzheimers Dis; 2020; 73(4):1511-1523. PubMed ID: 31929165
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.
Sahoo A; Bejanin A; Murray ME; Tosakulwong N; Weigand SD; Serie AM; Senjem ML; Machulda MM; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Dickson DW; Whitwell JL; Josephs KA
J Alzheimers Dis; 2018; 64(4):1227-1233. PubMed ID: 30010126
[TBL] [Abstract][Full Text] [Related]
8. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype.
Josephs KA; Whitwell JL; Knopman DS; Hu WT; Stroh DA; Baker M; Rademakers R; Boeve BF; Parisi JE; Smith GE; Ivnik RJ; Petersen RC; Jack CR; Dickson DW
Neurology; 2008 May; 70(19 Pt 2):1850-7. PubMed ID: 18401022
[TBL] [Abstract][Full Text] [Related]
9. Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer's disease: a case-control study.
Buciuc M; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Boeve BF; Knopman DS; Parisi JE; Petersen RC; Dickson DW; Josephs KA
Neurobiol Aging; 2020 Aug; 92():92-97. PubMed ID: 32408057
[TBL] [Abstract][Full Text] [Related]
10. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
Wolk DA; Dickerson BC;
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10256-61. PubMed ID: 20479234
[TBL] [Abstract][Full Text] [Related]
12. Staging TDP-43 pathology in Alzheimer's disease.
Josephs KA; Murray ME; Whitwell JL; Parisi JE; Petrucelli L; Jack CR; Petersen RC; Dickson DW
Acta Neuropathol; 2014 Mar; 127(3):441-50. PubMed ID: 24240737
[TBL] [Abstract][Full Text] [Related]
13. Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer's disease and cerebrovascular disease pathologies.
Katsumata Y; Fardo DW; Kukull WA; Nelson PT
Acta Neuropathol Commun; 2018 Dec; 6(1):142. PubMed ID: 30567576
[TBL] [Abstract][Full Text] [Related]
14. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).
Josephs KA; Murray ME; Tosakulwong N; Whitwell JL; Knopman DS; Machulda MM; Weigand SD; Boeve BF; Kantarci K; Petrucelli L; Lowe VJ; Jack CR; Petersen RC; Parisi JE; Dickson DW
Acta Neuropathol; 2017 May; 133(5):705-715. PubMed ID: 28160067
[TBL] [Abstract][Full Text] [Related]
15. TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease.
Bigio EH; Mishra M; Hatanpaa KJ; White CL; Johnson N; Rademaker A; Weitner BB; Deng HX; Dubner SD; Weintraub S; Mesulam M
Acta Neuropathol; 2010 Jul; 120(1):43-54. PubMed ID: 20361198
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.
Davidson YS; Raby S; Foulds PG; Robinson A; Thompson JC; Sikkink S; Yusuf I; Amin H; DuPlessis D; Troakes C; Al-Sarraj S; Sloan C; Esiri MM; Prasher VP; Allsop D; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
Acta Neuropathol; 2011 Dec; 122(6):703-13. PubMed ID: 21968532
[TBL] [Abstract][Full Text] [Related]
17. Genetic risk for Alzheimer's disease alters the five-year trajectory of semantic memory activation in cognitively intact elders.
Rao SM; Bonner-Jackson A; Nielson KA; Seidenberg M; Smith JC; Woodard JL; Durgerian S
Neuroimage; 2015 May; 111():136-46. PubMed ID: 25687593
[TBL] [Abstract][Full Text] [Related]
18. Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
Mohanty R; Ferreira D; Frerich S; Muehlboeck JS; Grothe MJ; Westman E;
Neurology; 2022 Jul; 99(4):e323-e333. PubMed ID: 35609990
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.
Nag S; Yu L; Capuano AW; Wilson RS; Leurgans SE; Bennett DA; Schneider JA
Ann Neurol; 2015 Jun; 77(6):942-52. PubMed ID: 25707479
[TBL] [Abstract][Full Text] [Related]
20. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.
Whitwell JL; Dickson DW; Murray ME; Weigand SD; Tosakulwong N; Senjem ML; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Jack CR; Josephs KA
Lancet Neurol; 2012 Oct; 11(10):868-77. PubMed ID: 22951070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
